{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:31:21Z","timestamp":1790008281929,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.leukres.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T01:57:54Z","timestamp":1442109474000},"page":"1342-1346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis"],"prefix":"10.1016","volume":"39","author":[{"given":"Smith","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benny","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Jamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1046\/j.1365-2141.1999.01636.x","article-title":"Acute lymphoblastic leukaemia occuring as second malignancy: report of the GIMEMA archive of adult acute leukaemia","volume":"106","author":"Pagano","year":"1999","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2015.09.011_bib0010","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.011_bib0015","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/cncr.26735","article-title":"Therapy-related acute lymphoblastic leukemia is more frequent than previously recognized and has a poor prognosis","volume":"118","author":"Abdulwahab","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2015.09.011_bib0020","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.leu.2402918","article-title":"High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities","volume":"17","author":"Ishizawa","year":"2003","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.leukres.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdn182","article-title":"Biologic features and treatment outcome of secondary acute lymphoblastic leukemia- a review of 101 cases","volume":"19","author":"Shivakumar","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2015.09.011_bib0030","unstructured":"Surveillance, Epidemiology, and End Results (SEER) program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 13 Regs Research Data (with SEER Delay Factors), Nov 2013 Sub (1992\u20132011) <Katrina\/Rita Population Adjustment> - Linked To County Attributes- Total U.S., 1969\u20132012 Counties, National Cancer Institute, DCCPS, surveillance research program, surveillance systems branch, released April 2014, based on the November 2013 submission."},{"issue":"8","key":"10.1016\/j.leukres.2015.09.011_bib0035","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.011_bib0040","volume":"vol. 6","author":"Curtis Ries","year":"2006"},{"issue":"1","key":"10.1016\/j.leukres.2015.09.011_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pan\/mpr013","article-title":"Matching for causal inference without balance checking","volume":"20","author":"Iacus","year":"2009","journal-title":"Political Anal."},{"issue":"4","key":"10.1016\/j.leukres.2015.09.011_bib0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1037\/a0014268","article-title":"Average causal effects from nonrandomized studies: a practical guide and simulated example","volume":"13","author":"Schafer","year":"2008","journal-title":"Psychol. Methods"},{"issue":"20","key":"10.1016\/j.leukres.2015.09.011_bib0055","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial","volume":"22","author":"XT","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.leukres.2015.09.011_bib0060","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","article-title":"Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 Trial","volume":"22","author":"Thomas","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2015.09.011_bib0065","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","article-title":"Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study","volume":"99","author":"Annino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2015.09.011_bib0070","doi-asserted-by":"crossref","unstructured":"L. Annino, L., et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Vol. 99. 2002. 863\u2013871.","DOI":"10.1182\/blood.V99.3.863"},{"key":"10.1016\/j.leukres.2015.09.011_bib0075","article-title":"Secondary acute lymphoblastic leukemia after primary solid organ malignancy: a SEER Analysis of incidence and outcomes","author":"Swaika","year":"2014","journal-title":"Poster Presentation (ASH)"},{"key":"10.1016\/j.leukres.2015.09.011_bib0080","article-title":"Secondary ALL May be independent of prior cytotoxic therapy","author":"Ganzel","year":"2014","journal-title":"Poster Presentation (ASH)"},{"key":"10.1016\/j.leukres.2015.09.011_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/AJCPYWC6AQC7BAVJ","article-title":"Therapy-related acute lymphoblastic leukemia without 11q23 abnormality","volume":"133","author":"Chen","year":"2010","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2015.09.011_bib0090","article-title":"Therapy-related acute lymphoblastic leukemia: cytogenetic features and hematopoietic cell transplantation outcome","author":"Aldoss","year":"2014","journal-title":"Poster Presentation (ASH)"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212615303829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T12:46:54Z","timestamp":1567169214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212615303829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0145212615303829"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}